ESTEVE PHARMACEUTICALS LTD
Get an alert when ESTEVE PHARMACEUTICALS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.6m
+124.1% highest in 3 filed years
Net assets
£5.4m
-10.7% lowest in 3 filed years
Employees
15
+25% highest in 3 filed years
Profit before tax
-£656k
-286.2% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £12,321,003 | £14,788,058 | £19,294,787 | +30.5% | |
| Operating profit | £181,999 | £318,754 | -£670,058 | -310.2% | |
| Profit before tax | £208,280 | £352,281 | -£655,915 | -286.2% | |
| Net profit | £208,280 | £352,281 | -£655,915 | -286.2% | |
| Cash | £197,780 | £695,463 | £1,558,193 | +124.1% | |
| Total assets less current liabilities | £5,752,888 | £6,105,169 | £5,449,254 | -10.7% | |
| Net assets | £5,752,888 | £6,105,169 | £5,449,254 | -10.7% | |
| Equity | £5,752,888 | £6,105,169 | £5,449,254 | -10.7% | |
| Average employees | 12 | 12 | 15 | +25% | |
| Wages | £844,117 | £1,159,196 | £1,367,190 | +17.9% | |
| Directors' remuneration | — | — | — | — | |
| Highest paid director | — | — | £194,851 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 1.5% | 2.2% | -3.5% | |
| Net margin | 1.7% | 2.4% | -3.4% | |
| Return on capital employed | 3.2% | 5.2% | -12.3% | |
| Gearing (liabilities / total assets) | 23.2% | 28.2% | 61.7% | |
| Current ratio | 3.94x | 3.20x | 1.53x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ESTEVE PHARMACEUTICALS LTD 2021-11-15 → present
- INTRAPHARM LABORATORIES LIMITED 1997-08-15 → 2021-11-15
- TORBET HEALTHCARE LIMITED 1997-06-27 → 1997-08-15
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis. The company remains assured of the financial support provided by Esteve Healthcare S.L., the ultimate controlling party.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALL, Scott Douglas | Director | 2025-02-17 | Nov 1971 | British |
| TOLSTRUP, Jacob | Director | 2025-01-15 | May 1972 | Danish |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HODGES, Carole Mabel | Secretary | 1997-06-27 | 2003-04-16 |
| MICHAEL, Gregory Morris | Secretary | 2009-05-13 | 2014-08-07 |
| PATEL, Bhupendra | Secretary | 2003-04-16 | 2009-05-13 |
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 1997-06-27 | 1997-06-27 |
| DE MELLO BARRETO, Goncalo Jose Geada | Director | 2024-01-01 | 2025-01-28 |
| HODGES, Norman Anthony Lavis | Director | 1997-06-27 | 2009-05-13 |
| JAMES, Kevin | Director | 2009-05-13 | 2018-10-16 |
| JUST, Rene | Director | 2019-01-23 | 2020-03-04 |
| MICHAEL, Gregory Morris | Director | 2009-05-13 | 2014-08-07 |
| MUNTAÑOLA PRAT, Jorge | Director | 2020-02-19 | 2025-01-15 |
| PATEL, Bhupendra | Director | 2002-08-28 | 2009-05-13 |
| SALZER, Uwe, Dr. | Director | 2016-09-01 | 2018-08-31 |
| SHAFIQ, Mohammed Choudhary, Dr | Director | 2009-05-13 | 2020-09-30 |
| VON ALVENSLEBEN, Konstantin | Director | 2016-06-30 | 2020-03-03 |
| VON BUCHWALDT, Beatrix | Director | 2016-06-30 | 2016-08-31 |
| WRIGHT, Philip John | Director | 2015-01-02 | 2016-01-29 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 1997-06-27 | 1997-06-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mrs Montserrat Esteve Soler | Individual | Shares 25–50%, Voting 25–50% | 2021-07-01 | Ceased 2023-07-10 |
| Riemser Pharma Uk Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2021-07-01 |
Filing timeline
Last 20 of 140 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-07 MA Memorandum articles
- 2025-02-07 RESOLUTIONS Resolution
- 2024-01-08 MA Memorandum articles
- 2024-01-08 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-08 | AA | accounts | Accounts with accounts type full | |
| 2026-08-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-08-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-19 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-07 | MA | incorporation | Memorandum articles | |
| 2025-02-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-20 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-17 | AA | accounts | Accounts with accounts type full | |
| 2024-08-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-08 | MA | incorporation | Memorandum articles | |
| 2024-01-08 | RESOLUTIONS | resolution | Resolution | |
| 2024-01-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-04 | AA | accounts | Accounts with accounts type full | |
| 2023-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-03 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2023-08-03 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-08-25 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.